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Introduction
In the past few years the use of musculoskeletal ultrasound
(MSUS) in pediatric rheumatology has proven to be better
than clinical examination in detecting synovitis. Beside
standard power doppler ultrasound (PDUS), vasculariza-
tion of the tissues can be assessed using 3D/4D PD sono-
graphy. Using this technique, we can now assess a virtually
reconstructed vascular tree within a volume of interest
and can ‘objectively’ determine its vascularization by
calculating indices using the specially designed VOCALTM
software (Virtual Organ Computer-aided AnaLysis). 3D/
4D US is a well established method for determination of
accurate vascularity and blood flow in the field of
obstetrics and gynecology, but limited data is available in
rheumatology patients.
Objectives
To describe and investigate the ability of 3D/4D PD
sonography in accurately predicting vascular and clinical
response to IA infliximab (INF) or triamcinolone hexace-
tonide (TCH) in knee joints of JIA patients.
Methods
JIA patients (n=15) with clinically active knee synovitis
underwent IA injection of either IFX (50 mg/kg; 13 joints
in 9 patients) or TCH (1 mg/kg; 8 joints in 6 patients). All
patients were treated with first and second line therapy
(NSAID, DMARD, corticosteroids). The 3D/4D virtual
vascular sonobiopsy was performed by experienced rheu-
matologists. Patients were examined with the Medison
Samsung Accuvix V10 US using a 3D/4D linear probe
with 6.2 MHz PD frequency (PRF 1 kHz, gain 45). The
VOCALTM software was utilized to calculate volume of
predesigned spheras in the five standardized positions
adjusted for the IA size using a specially designed grid.
Subsequently, the software automatically displayed sphere
volume and three 3D indices: vascularization index (VI),
flow index (FI) and vascularization and flow index (VFI).
The indices are assumed to reflect the number of vessels
within the volume of interest (VI), intensity of flow at the
time of 3D sweep (FI), and both blood flow and vasculari-
zation (VFI), respectively. Clinical (JADAS) and sono-
graphic (3D/4D US) examination was preformed before
and after therapy. To compare indices and analyze correla-
tions, paired samples t-test and Pearson’s test were used.
Results
In total, 21 joints in 15 patients were analyzed using
VOCAL software. At the time of IA injections with INF,
13 joints of 9 patients showed grade 3 synovitis in B
mode with increased PD signal (2-3/3), while 8 joints of
6 patients treated with TCH showed grade 1-2 synovitis
in B mode and increased PD signal (1-2/3). The mean
time for follow up was 6.5 months (range 3- 11) for
IFX, and 2.8 months (range 1.5-6) for TCH treated
patients, respectively. The VI index was expressed as
percentage, and both FI and VFI as values of 1-100/
cm3. There were significant differences in mean value of
VI (p=0,03) and FI/SW (p=0,02) in patients treated with
IFX, as well as in JADAS value (p<0,01) in both groups
of treated patients. Statistical analysis also showed
significant correlations among used indexes.
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Conclusion
3D/4D US appears a valid, sensitive-to-change and fea-
sible method for evaluating knee joint inflammation/
vascularization, and possible outcome measure in chil-
dren with mono/oligoarticular JIA treated with IA
TCH, or in selected patients with IA IFX. Further mul-
ticenter studies including larger number of patients,
other joints and intra and interobserver variability are
warranted, before 3D/4D US may be applied as a valid
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